glp-1 telehealth crackdown news today FDA Targets Compounded Marketing in New Warning Letters FEDS CRACK DOWN ON TELEHEALTH

The FAERS database also revealed 41 reported cases for semaglutide with an ROR of 11.36 (95% CI, 8.33 to 15.49) and a PRR of 11.36 (95% CI, 8.32 to 15.47), suggesting a potential causal relationship between semaglutide and NAION [98]

That posture is difficult to square with MEDVis April 8 statement that the company had only recently become aware of ads featuring potentially AI-generated medical practitioners. By April 3, Gallagher was already publicly mocking critics and equating the fake-doctor imagery with ordinary stock-art marketing

What is GLP-1

The interpretation of clinical outcomes in some retrospective studies remains problematic

In comparable trials of injectable Wegovy, participants lost approximately 15% of body weight over a similar period

Obesity Pillars, 12 , 100127